Publikationen, an denen er mitarbeitet CARLOS MANUEL GONZALEZ CASIMIRO (8)

2024

  1. Correction to: Insulin-degrading enzyme ablation in mouse pancreatic alpha cells triggers cell proliferation, hyperplasia and glucagon secretion dysregulation (Diabetologia, (2022), 65, 8, (1375-1389), 10.1007/s00125-022-05729-y)

    Diabetologia

2022

  1. Altered Surface Expression of Insulin-Degrading Enzyme on Monocytes and Lymphocytes from COVID-19 Patients Both at Diagnosis and after Hospital Discharge

    International Journal of Molecular Sciences, Vol. 23, Núm. 19

  2. Insulin-degrading enzyme ablation in mouse pancreatic alpha cells triggers cell proliferation, hyperplasia and glucagon secretion dysregulation

    Diabetologia, Vol. 65, Núm. 8, pp. 1375-1389

  3. Primary Cilia in Pancreatic β- and α-Cells: Time to Revisit the Role of Insulin-Degrading Enzyme

    Frontiers in Endocrinology, Vol. 13

2021

  1. Effects of fasting and feeding on transcriptional and posttranscriptional regulation of insulin‐degrading enzyme in mice

    Cells, Vol. 10, Núm. 9

  2. Modulation of insulin sensitivity by insulin-degrading enzyme

    Biomedicines, Vol. 9, Núm. 1, pp. 1-38

  3. Targeting insulin-degrading enzyme in insulin clearance

    International Journal of Molecular Sciences, Vol. 22, Núm. 5, pp. 1-21

2020

  1. Hepatic insulin-degrading enzyme regulates glucose and insulin homeostasis in diet-induced obese mice

    Metabolism: Clinical and Experimental, Vol. 113